Wexford Capital’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-46,352
| Closed | -$303K | – | 250 |
|
|
2025
Q1 | $303K | Buy |
46,352
+42,747
| +1,186% | +$279K | 0.08% | 161 |
|
|
2024
Q4 | $236K | Hold |
3,605
| – | – | 0.04% | 153 |
|
|
2024
Q3 | $281K | Sell |
3,605
-7,859
| -69% | -$612K | 0.07% | 132 |
|
|
2024
Q2 | $894K | Sell |
11,464
-64,326
| -85% | -$5.02M | 0.23% | 72 |
|
|
2024
Q1 | $5.13M | Sell |
75,790
-49,611
| -40% | -$3.36M | 1.05% | 28 |
|
|
2023
Q4 | $8.45M | Buy |
125,401
+36,607
| +41% | +$2.47M | 1.81% | 10 |
|
|
2023
Q3 | $6.01M | Buy |
88,794
+31,897
| +56% | +$2.16M | 1.33% | 19 |
|
|
2023
Q2 | $4.07M | Sell |
56,897
-20,116
| -26% | -$1.44M | 0.81% | 35 |
|
|
2023
Q1 | $5.35M | Buy |
77,013
+73,408
| +2,036% | +$5.1M | 1.11% | 23 |
|
|
2022
Q4 | $244K | Buy |
+3,605
| New | +$244K | 0.05% | 108 |
|
|
2022
Q3 | – | Sell |
-3,578
| Closed | -$236 | – | 140 |
|
|
2022
Q2 | $236 | Hold |
3,578
| – | – | 0.01% | 154 |
|
|
2022
Q1 | $237 | Buy |
3,578
+51
| +1% | +$3 | 0.01% | 136 |
|
|
2021
Q4 | $205 | Buy |
+3,527
| New | +$205 | 0.01% | 178 |
|
|
2021
Q2 | $210K | Buy |
+3,500
| New | +$210K | 0.03% | 155 |
|
|
2021
Q1 | – | Sell |
-136,000
| Closed | -$6.8M | – | 211 |
|
|
2020
Q4 | $6.8M | Buy |
136,000
+102,819
| +310% | +$5.14M | 1.06% | 21 |
|
|
2020
Q3 | $1.82M | Sell |
33,181
-45,151
| -58% | -$2.47M | 0.49% | 51 |
|
|
2020
Q2 | $4.14M | Buy |
+78,332
| New | +$4.14M | 1.04% | 31 |
|
|
2019
Q1 | – | Sell |
-197,573
| Closed | -$7.5M | – | 93 |
|
|
2018
Q4 | $7.5M | Buy |
+197,573
| New | +$7.5M | 0.64% | 25 |
|
|
2014
Q4 | – | Sell |
-161,478
| Closed | -$5.77M | – | 57 |
|
|
2014
Q3 | $5.77M | Buy |
+161,478
| New | +$5.77M | 0.53% | 30 |
|